The Magazine for Sleep Professionals
Monday, September 28, 2026
ProSomnus, Inc. released the results of a survey conducted in partnership with Prodege, a cutting-edge consumer marketing and insights platform, on the major obstacles to identifying and treating snoring and OSA, including a lack of awareness of where to seek medical advice. Key findings of the survey of 1,000 people […]
ProSomnus, Inc. announced the presentation of four abstracts at the 2023 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, held May 19-21 in Philadelphia, Pennsylvania, and two abstracts at the American Thoracic Society (ATS) 2023 International Conference, held May 19-24 in Washington, D.C. The data presented at both meetings […]
Sleep Solutions, a regional medical equipment company based in Detroit that specializes in sleep and respiratory care, just completed a trial of 100 patients beginning CPAP. Of those, 50 patients received standard care, and 50 patients received standard care with the V̇-Com™ device (SleepRes, LLC, Murfreesboro, TN) in their CPAP […]
ProSomnus, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) has allowed a patent application covering the Company’s proprietary automated manufacturing process for the Company’s precision medical devices; this is the third patent to issue in this family, including already-issued USPN 10,213,280 and USPN 9,808,327. ProSomnus’s intellectual property […]
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces the FDA approval to remove dental contraindications for eXciteOSA. This opens the door for doctors and other providers to prescribe eXciteOSA on a more widespread basis. Based on an observational study conducted by Signifier Medical, the […]
Sunrise, announced the U.S. Food and Drug Administration (FDA) has cleared for use of its second-generation at-home sleep apnea test that uses artificial intelligence (AI) to aid in the diagnosis of obstructive sleep apnea and sleep-related breathing disorders. The Sunrise team is using a novel way to measure sleep through […]
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to treat obstructive sleep apnea (OSA) and related disorders, announced positive topline results from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study of one-month duration. The topline results were positive for the company’s lead candidate for […]
The U.S. Food and Drug Administration (FDA) is alerting patients, caregivers, and health care providers that Philips Respironics (Philips) recalled certain bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines that may contain a plastic contaminated with a non-compatible material. If that plastic is in the […]
SleepRes, LLC, the developers of the V̇-Com™, announces Bernard Hete, Ph.D. as their Chief Technology Officer to oversee future research and development. Dr. Hete has been a senior engineer at Philips Respironics for 30 years. “I get to work with a visionary sleep physician who is revolutionizing PAP therapy to […]
We all know someone who is “supposed” to wear their CPAP machine but doesn’t. The one who went through the process of having a custom dental appliance made but doesn’t bother to wear it. The one who continues to suffer from sleep deprivation because even when they did what they […]
